Sky Medical Technology

Sky Medical Technology Ltd. is a growth-stage bioelectronic medicine platform that is completely redefining the treatment of vascular-related diseases. The company has developed a neuromodulation therapy called OnPulse™, the first clinically validated bioelectronic compression technology for the prevention and treatment of various acute and chronic circulatory conditions. The first indication for the OnPulse wearable therapy includes life-threatening blood clots, post-orthopedic surgery swelling, long-term non-healing wounds, and applications to accelerate recovery time for professional athletes during competition breaks and travel. Currently, there is an unmet need for over 40 million people.